Winette van der Graaf
@winettevandergraaf.bsky.social
Prof of Med Onc #Sarcoma #AYA cancer #RareCancers @Netherlands Cancer Institute; ErasmusMC;
President @EORTC Brussels;
Chairman Dutch AYA cancer network #MedSky #OncSky #SARCsky #AYACSM
President @EORTC Brussels;
Chairman Dutch AYA cancer network #MedSky #OncSky #SARCsky #AYACSM
Reposted by Winette van der Graaf
EuropePMC.org is the alternative for PubMed, in case you have problems to access PubMed.
Europe PMCHome - Europe PMC
Europe PMC is an archive of life sciences journal literature.
EuropePMC.org
March 2, 2025 at 4:32 PM
EuropePMC.org is the alternative for PubMed, in case you have problems to access PubMed.
Worth reading for all of you interested in patient centric trials in oncology with dose optimisation as important aim.
The challenges in the current European landscape.
#DE-ESCALATE #CTR
@eortc.org
doi: 10.1016/j.ejca.2025.115790
The challenges in the current European landscape.
#DE-ESCALATE #CTR
@eortc.org
doi: 10.1016/j.ejca.2025.115790
November 9, 2025 at 5:35 PM
Worth reading for all of you interested in patient centric trials in oncology with dose optimisation as important aim.
The challenges in the current European landscape.
#DE-ESCALATE #CTR
@eortc.org
doi: 10.1016/j.ejca.2025.115790
The challenges in the current European landscape.
#DE-ESCALATE #CTR
@eortc.org
doi: 10.1016/j.ejca.2025.115790
Reposted by Winette van der Graaf
🎉 What a day at #EORTC #PatientDays!
Day 1 was packed with energy, empathy and honest round table talks.
Thanks to all who joined, your voices are shaping the future of cancer care.
👋 See you tomorrow!
🔗https://www.eortc.org/event/patient-days-2025/?tab=1
#CancerCare #PatientEngagement #Oncology
Day 1 was packed with energy, empathy and honest round table talks.
Thanks to all who joined, your voices are shaping the future of cancer care.
👋 See you tomorrow!
🔗https://www.eortc.org/event/patient-days-2025/?tab=1
#CancerCare #PatientEngagement #Oncology
November 6, 2025 at 4:15 PM
🎉 What a day at #EORTC #PatientDays!
Day 1 was packed with energy, empathy and honest round table talks.
Thanks to all who joined, your voices are shaping the future of cancer care.
👋 See you tomorrow!
🔗https://www.eortc.org/event/patient-days-2025/?tab=1
#CancerCare #PatientEngagement #Oncology
Day 1 was packed with energy, empathy and honest round table talks.
Thanks to all who joined, your voices are shaping the future of cancer care.
👋 See you tomorrow!
🔗https://www.eortc.org/event/patient-days-2025/?tab=1
#CancerCare #PatientEngagement #Oncology
Reposted by Winette van der Graaf
ESMO 2025: A leadership moment!
EORTC President @winettevandergraaf.bsky.social and incoming President @benjaminbessemd.bsky.social in action.
Sharing ideas, energy, and a vision for better cancer care across Europe.
Their presence at #ESMO25 says it all: Continuity Collaboration. Real impact.
EORTC President @winettevandergraaf.bsky.social and incoming President @benjaminbessemd.bsky.social in action.
Sharing ideas, energy, and a vision for better cancer care across Europe.
Their presence at #ESMO25 says it all: Continuity Collaboration. Real impact.
October 17, 2025 at 11:02 AM
ESMO 2025: A leadership moment!
EORTC President @winettevandergraaf.bsky.social and incoming President @benjaminbessemd.bsky.social in action.
Sharing ideas, energy, and a vision for better cancer care across Europe.
Their presence at #ESMO25 says it all: Continuity Collaboration. Real impact.
EORTC President @winettevandergraaf.bsky.social and incoming President @benjaminbessemd.bsky.social in action.
Sharing ideas, energy, and a vision for better cancer care across Europe.
Their presence at #ESMO25 says it all: Continuity Collaboration. Real impact.
The @eortc.org STBSG (sarcoma) group’s meeting in Lyon was a great success with a lot of ideas and interesting discussions.
Excellent talk about #ATLAS by
@saxotomy.bsky.social
Global trial options in rare diseases as #sarcoma possible!
Excellent talk about #ATLAS by
@saxotomy.bsky.social
Global trial options in rare diseases as #sarcoma possible!
October 10, 2025 at 1:13 PM
The @eortc.org STBSG (sarcoma) group’s meeting in Lyon was a great success with a lot of ideas and interesting discussions.
Excellent talk about #ATLAS by
@saxotomy.bsky.social
Global trial options in rare diseases as #sarcoma possible!
Excellent talk about #ATLAS by
@saxotomy.bsky.social
Global trial options in rare diseases as #sarcoma possible!
What an amazing group op people in this consortium.
Grateful for everyone’s contribution!
@strong-aya.bsky.social
Annual meeting # Paris
Grateful for everyone’s contribution!
@strong-aya.bsky.social
Annual meeting # Paris
It’s a wrap! Day 2 of the General Assembly brought inspiring discussions with input from our Patient Advisory Board.
Today's highlights:
• Cancer awareness campaigns that stick
• Update on the federated learning infrastructure and integrated data
• Steps for launching our public information portal
Today's highlights:
• Cancer awareness campaigns that stick
• Update on the federated learning infrastructure and integrated data
• Steps for launching our public information portal
October 7, 2025 at 5:58 PM
What an amazing group op people in this consortium.
Grateful for everyone’s contribution!
@strong-aya.bsky.social
Annual meeting # Paris
Grateful for everyone’s contribution!
@strong-aya.bsky.social
Annual meeting # Paris
Reposted by Winette van der Graaf
📍 We're in Paris for the #STRONGAYA General Assembly meeting, hosted by Institut Gustave Roussy.
Today, we discussed:
• Sustaining project results & reaching stakeholders
• Ethical health data processing for research
• Patient consent models
• Evaluating & refining our Core Outcome Set
Today, we discussed:
• Sustaining project results & reaching stakeholders
• Ethical health data processing for research
• Patient consent models
• Evaluating & refining our Core Outcome Set
October 6, 2025 at 3:01 PM
📍 We're in Paris for the #STRONGAYA General Assembly meeting, hosted by Institut Gustave Roussy.
Today, we discussed:
• Sustaining project results & reaching stakeholders
• Ethical health data processing for research
• Patient consent models
• Evaluating & refining our Core Outcome Set
Today, we discussed:
• Sustaining project results & reaching stakeholders
• Ethical health data processing for research
• Patient consent models
• Evaluating & refining our Core Outcome Set
Reposted by Winette van der Graaf
📖 New STRONG AYA Resource:
The Blueprint for building national and pan-European STRONG AYA ecosystems to improve AYA cancer care is now available on our website.
👉 Read the full blueprint with information on data ecosystem structures, governance, standards & challenges: strongaya.eu/wp-content/u...
The Blueprint for building national and pan-European STRONG AYA ecosystems to improve AYA cancer care is now available on our website.
👉 Read the full blueprint with information on data ecosystem structures, governance, standards & challenges: strongaya.eu/wp-content/u...
September 17, 2025 at 8:57 AM
📖 New STRONG AYA Resource:
The Blueprint for building national and pan-European STRONG AYA ecosystems to improve AYA cancer care is now available on our website.
👉 Read the full blueprint with information on data ecosystem structures, governance, standards & challenges: strongaya.eu/wp-content/u...
The Blueprint for building national and pan-European STRONG AYA ecosystems to improve AYA cancer care is now available on our website.
👉 Read the full blueprint with information on data ecosystem structures, governance, standards & challenges: strongaya.eu/wp-content/u...
Reposted by Winette van der Graaf
📄 Publication alert: Recommendations and roadmap to implement minimum standards of specialist adolescent and young adult #AYA cancer care units
Led and co-authored by AYAs under the EU-CAYAS-NET project and featuring STRONG-AYA among EU initiatives.
👉 www.sciencedirect.com/science/arti...
Led and co-authored by AYAs under the EU-CAYAS-NET project and featuring STRONG-AYA among EU initiatives.
👉 www.sciencedirect.com/science/arti...
Minimum standards of specialist adolescent and young adult (AYA) cancer care units: recommendations and implementation roadmap
In 2022, according to the Global Cancer Observatory, >115 000 adolescents and young adults (AYAs; aged 15-39 years) were diagnosed with cancer across …
www.sciencedirect.com
October 3, 2025 at 2:25 PM
📄 Publication alert: Recommendations and roadmap to implement minimum standards of specialist adolescent and young adult #AYA cancer care units
Led and co-authored by AYAs under the EU-CAYAS-NET project and featuring STRONG-AYA among EU initiatives.
👉 www.sciencedirect.com/science/arti...
Led and co-authored by AYAs under the EU-CAYAS-NET project and featuring STRONG-AYA among EU initiatives.
👉 www.sciencedirect.com/science/arti...
Grateful for the collaboration with @youthcancereurope.bsky.social showcasing minimal standards of AYA care units. Much can be found in the Dutch AYAZORGNETWERK.nl but we take the recoomendations into account to further improve the care. Published in @ESMO Open.
October 1, 2025 at 11:05 PM
Grateful for the collaboration with @youthcancereurope.bsky.social showcasing minimal standards of AYA care units. Much can be found in the Dutch AYAZORGNETWERK.nl but we take the recoomendations into account to further improve the care. Published in @ESMO Open.
Very interesting session with speakers from Japan, India, Slovenia, Jordan, South Africa and South Korea.
Language matters, cultural sensitivity even more, particularly in Quality of Life Research. There’s work to do!
Happy to have introduced the topic showing other global activities @eortc.org
Language matters, cultural sensitivity even more, particularly in Quality of Life Research. There’s work to do!
Happy to have introduced the topic showing other global activities @eortc.org
💡 Insightful panel discussion as part of @eortc.org #QualityofLife Group autumn meeting closing plenary session.
We look forward to broadening our collaborations in global context🤝
#QLGmeeting #GivingVoice2Patients
@winettevandergraaf.bsky.social @miekevhr.bsky.social
www.eortc.org/event/eortc-...
We look forward to broadening our collaborations in global context🤝
#QLGmeeting #GivingVoice2Patients
@winettevandergraaf.bsky.social @miekevhr.bsky.social
www.eortc.org/event/eortc-...
September 27, 2025 at 5:21 PM
Very interesting session with speakers from Japan, India, Slovenia, Jordan, South Africa and South Korea.
Language matters, cultural sensitivity even more, particularly in Quality of Life Research. There’s work to do!
Happy to have introduced the topic showing other global activities @eortc.org
Language matters, cultural sensitivity even more, particularly in Quality of Life Research. There’s work to do!
Happy to have introduced the topic showing other global activities @eortc.org
Reposted by Winette van der Graaf
🔔 New in @thelancetoncol.bsky.social:
Policy review led by Ian Tannock & Madeline Pe with EORTC & CSO highlights the critical role of patient quality of life data in the evaluation of treatments for people with advanced cancer.
📖Read more: www.eortc.org/blog/2025/09...
#CancerResearch #QualityofLife
Policy review led by Ian Tannock & Madeline Pe with EORTC & CSO highlights the critical role of patient quality of life data in the evaluation of treatments for people with advanced cancer.
📖Read more: www.eortc.org/blog/2025/09...
#CancerResearch #QualityofLife
September 2, 2025 at 12:05 PM
🔔 New in @thelancetoncol.bsky.social:
Policy review led by Ian Tannock & Madeline Pe with EORTC & CSO highlights the critical role of patient quality of life data in the evaluation of treatments for people with advanced cancer.
📖Read more: www.eortc.org/blog/2025/09...
#CancerResearch #QualityofLife
Policy review led by Ian Tannock & Madeline Pe with EORTC & CSO highlights the critical role of patient quality of life data in the evaluation of treatments for people with advanced cancer.
📖Read more: www.eortc.org/blog/2025/09...
#CancerResearch #QualityofLife
Reposted by Winette van der Graaf
📅 Get ready to make the most of EORTC’s upcoming events!
Mark your calendars 👇
#CancerResearch #ClinicalTrials #Oncology #EORTCevents #PatientDays #EBCC15 #Stats2026 #MCCRworkshop #ENASymp26
Mark your calendars 👇
#CancerResearch #ClinicalTrials #Oncology #EORTCevents #PatientDays #EBCC15 #Stats2026 #MCCRworkshop #ENASymp26
June 25, 2025 at 10:38 AM
📅 Get ready to make the most of EORTC’s upcoming events!
Mark your calendars 👇
#CancerResearch #ClinicalTrials #Oncology #EORTCevents #PatientDays #EBCC15 #Stats2026 #MCCRworkshop #ENASymp26
Mark your calendars 👇
#CancerResearch #ClinicalTrials #Oncology #EORTCevents #PatientDays #EBCC15 #Stats2026 #MCCRworkshop #ENASymp26
Reposted by Winette van der Graaf
📅 Attending ESMO in Berlin? Don't miss this special CSO Symposium taking place on Fri Oct 17, 5:30-7:00 pm CET.
Moderated by @winettevandergraaf.bsky.social, the panel will discuss recent CSO initiatives & activities in Europe & beyond.
tinyurl.com/5yj9vm8b
@qol.eortc.org #CommonSenseOncology
Moderated by @winettevandergraaf.bsky.social, the panel will discuss recent CSO initiatives & activities in Europe & beyond.
tinyurl.com/5yj9vm8b
@qol.eortc.org #CommonSenseOncology
September 15, 2025 at 6:50 PM
📅 Attending ESMO in Berlin? Don't miss this special CSO Symposium taking place on Fri Oct 17, 5:30-7:00 pm CET.
Moderated by @winettevandergraaf.bsky.social, the panel will discuss recent CSO initiatives & activities in Europe & beyond.
tinyurl.com/5yj9vm8b
@qol.eortc.org #CommonSenseOncology
Moderated by @winettevandergraaf.bsky.social, the panel will discuss recent CSO initiatives & activities in Europe & beyond.
tinyurl.com/5yj9vm8b
@qol.eortc.org #CommonSenseOncology
Reposted by Winette van der Graaf
Applications for the 2026 Common Sense Oncology Cancer Health Services Research Fellowship will close on Sept 18, 2025 @ 4 pm EDT. If you are in the clinical or medical oncology field, this opportunity is for you!
View the posting online: tinyurl.com/37cdc5sy
#CommonSenseOncology #CancerCare
View the posting online: tinyurl.com/37cdc5sy
#CommonSenseOncology #CancerCare
September 3, 2025 at 6:40 PM
Applications for the 2026 Common Sense Oncology Cancer Health Services Research Fellowship will close on Sept 18, 2025 @ 4 pm EDT. If you are in the clinical or medical oncology field, this opportunity is for you!
View the posting online: tinyurl.com/37cdc5sy
#CommonSenseOncology #CancerCare
View the posting online: tinyurl.com/37cdc5sy
#CommonSenseOncology #CancerCare
Reposted by Winette van der Graaf
Common Sense Oncology is now on #BlueSky! We are a global network dedicated to advancing innovative patient-centred cancer care & cancer research that meaningfully improves outcomes for patients around the world.
Join us to keep in touch—membership is free!
tinyurl.com/mrjtu9at #CommonSenseOncology
Join us to keep in touch—membership is free!
tinyurl.com/mrjtu9at #CommonSenseOncology
September 3, 2025 at 3:46 PM
Common Sense Oncology is now on #BlueSky! We are a global network dedicated to advancing innovative patient-centred cancer care & cancer research that meaningfully improves outcomes for patients around the world.
Join us to keep in touch—membership is free!
tinyurl.com/mrjtu9at #CommonSenseOncology
Join us to keep in touch—membership is free!
tinyurl.com/mrjtu9at #CommonSenseOncology
Substandard anticancer medications in clinical care settings and private pharmacies in sub-Saharan Africa: a systematic pharmaceutical investigation - The Lancet Global Health www.thelancet.com/journals/lan...
This is awful.
This is awful.
Substandard anticancer medications in clinical care settings and private pharmacies in sub-Saharan Africa: a systematic pharmaceutical investigation
Oncology practitioners and health systems in sub-Saharan Africa need to be aware of
the possible presence of substandard anticancer products when designing care protocols
and evaluating patient outcom...
www.thelancet.com
June 28, 2025 at 5:01 AM
Substandard anticancer medications in clinical care settings and private pharmacies in sub-Saharan Africa: a systematic pharmaceutical investigation - The Lancet Global Health www.thelancet.com/journals/lan...
This is awful.
This is awful.
Reposted by Winette van der Graaf
📢Excited to announce @benjaminbessemd.bsky.social as EORTC President-Elect, starting in June 2026, following @winettevandergraaf.bsky.social 🙌
Also, we welcome the new chairs of the Scientific Chairs Council: Anne-Marie Dingemans and Jean-Pascal Machiels!🔬🎉
👉 www.eortc.org/blog/2025/06...
Also, we welcome the new chairs of the Scientific Chairs Council: Anne-Marie Dingemans and Jean-Pascal Machiels!🔬🎉
👉 www.eortc.org/blog/2025/06...
June 27, 2025 at 2:31 PM
📢Excited to announce @benjaminbessemd.bsky.social as EORTC President-Elect, starting in June 2026, following @winettevandergraaf.bsky.social 🙌
Also, we welcome the new chairs of the Scientific Chairs Council: Anne-Marie Dingemans and Jean-Pascal Machiels!🔬🎉
👉 www.eortc.org/blog/2025/06...
Also, we welcome the new chairs of the Scientific Chairs Council: Anne-Marie Dingemans and Jean-Pascal Machiels!🔬🎉
👉 www.eortc.org/blog/2025/06...
Reposted by Winette van der Graaf
🔍Presenting at #ASCO25 as a #poster and now LIVE on our website
Predictors of withdrawal of anticancer drug indications granted accelerated approval: a retrospective cohort study
Read the whole paper here: www.thelancet.com/journals/ecl...
#TheLancet #Oncology #OncologyResearch #MedSky
Predictors of withdrawal of anticancer drug indications granted accelerated approval: a retrospective cohort study
Read the whole paper here: www.thelancet.com/journals/ecl...
#TheLancet #Oncology #OncologyResearch #MedSky
June 2, 2025 at 2:47 PM
🔍Presenting at #ASCO25 as a #poster and now LIVE on our website
Predictors of withdrawal of anticancer drug indications granted accelerated approval: a retrospective cohort study
Read the whole paper here: www.thelancet.com/journals/ecl...
#TheLancet #Oncology #OncologyResearch #MedSky
Predictors of withdrawal of anticancer drug indications granted accelerated approval: a retrospective cohort study
Read the whole paper here: www.thelancet.com/journals/ecl...
#TheLancet #Oncology #OncologyResearch #MedSky
Reposted by Winette van der Graaf
Prevention of sacituzumab govitecan-related neutropenia and diarrhea in patients with HER2-negative advanced breast cancer
Primary prophylactic G-CSF and loperamide led to a clinically relevant reduced incidence and severity of neutropenia and diarrhea
www.thelancet.com/journals/ecl...
#MedSky
Primary prophylactic G-CSF and loperamide led to a clinically relevant reduced incidence and severity of neutropenia and diarrhea
www.thelancet.com/journals/ecl...
#MedSky
June 20, 2025 at 9:31 AM
Prevention of sacituzumab govitecan-related neutropenia and diarrhea in patients with HER2-negative advanced breast cancer
Primary prophylactic G-CSF and loperamide led to a clinically relevant reduced incidence and severity of neutropenia and diarrhea
www.thelancet.com/journals/ecl...
#MedSky
Primary prophylactic G-CSF and loperamide led to a clinically relevant reduced incidence and severity of neutropenia and diarrhea
www.thelancet.com/journals/ecl...
#MedSky
New paper on implementation of WGS in sarcoma routine medical care in a sarcoma expert center. WGS results of 161 STS were assessed. Actionable targets in 46%, subtype specific added value of WGS. Less in fusion pos STS, more in complex ones.
kwnsfk27.r.eu-west-1.awstrack.me/L0/https:%2F...
kwnsfk27.r.eu-west-1.awstrack.me/L0/https:%2F...
ScienceDirect.com | Science, health and medical journals, full text articles and books.
kwnsfk27.r.eu-west-1.awstrack.me
June 21, 2025 at 7:42 AM
New paper on implementation of WGS in sarcoma routine medical care in a sarcoma expert center. WGS results of 161 STS were assessed. Actionable targets in 46%, subtype specific added value of WGS. Less in fusion pos STS, more in complex ones.
kwnsfk27.r.eu-west-1.awstrack.me/L0/https:%2F...
kwnsfk27.r.eu-west-1.awstrack.me/L0/https:%2F...
Immensely proud of my colleague and friend Christopher Booth @Queens’s University Kingston who will present the positive results of Challenge #ASCO25 today. Together with Publication in @nejm.org Impressive work. meetings.asco.org/2025-asco-an...
June 1, 2025 at 12:54 PM
Immensely proud of my colleague and friend Christopher Booth @Queens’s University Kingston who will present the positive results of Challenge #ASCO25 today. Together with Publication in @nejm.org Impressive work. meetings.asco.org/2025-asco-an...
A new paper from a workshop on pragmatic clinical trials in cancer organised by @eortc.org published in Lancet Oncology.
Fabulous group of co-authors who took part in the workshop. Access to drugs that matter to
patients as ultimate goal.
eur05.safelinks.protection.outlook.com?url=https%3A...
Fabulous group of co-authors who took part in the workshop. Access to drugs that matter to
patients as ultimate goal.
eur05.safelinks.protection.outlook.com?url=https%3A...
eur05.safelinks.protection.outlook.com
May 3, 2025 at 8:49 AM
A new paper from a workshop on pragmatic clinical trials in cancer organised by @eortc.org published in Lancet Oncology.
Fabulous group of co-authors who took part in the workshop. Access to drugs that matter to
patients as ultimate goal.
eur05.safelinks.protection.outlook.com?url=https%3A...
Fabulous group of co-authors who took part in the workshop. Access to drugs that matter to
patients as ultimate goal.
eur05.safelinks.protection.outlook.com?url=https%3A...
Reposted by Winette van der Graaf
🤝As the clinical trial landscape evolves, so must our strategies for measuring patients’ #QualityofLife to ensure their voice is incorporated in the decision-making process
🔎Takeaways from new article in @thelancetoncol.bsky.social: www.eortc.org/blog/2025/04...
#GivingVoice2Patients @ema.europa.eu
🔎Takeaways from new article in @thelancetoncol.bsky.social: www.eortc.org/blog/2025/04...
#GivingVoice2Patients @ema.europa.eu
🔎New in @thelancetoncol.bsky.social: Insights from @ema.europa.eu-EORTC workshop underscore the role of #QualityofLife data in cancer treatment evaluation.
It’s not just about survival-it’s also about how patients live.
Read more in our press release:
www.eortc.org/blog/2025/04...
#CancerResearch
It’s not just about survival-it’s also about how patients live.
Read more in our press release:
www.eortc.org/blog/2025/04...
#CancerResearch
April 15, 2025 at 4:27 PM
🤝As the clinical trial landscape evolves, so must our strategies for measuring patients’ #QualityofLife to ensure their voice is incorporated in the decision-making process
🔎Takeaways from new article in @thelancetoncol.bsky.social: www.eortc.org/blog/2025/04...
#GivingVoice2Patients @ema.europa.eu
🔎Takeaways from new article in @thelancetoncol.bsky.social: www.eortc.org/blog/2025/04...
#GivingVoice2Patients @ema.europa.eu